» Articles » PMID: 23025592

Aerosolized Antimicrobial Agents Based on Degradable Dextran Nanoparticles Loaded with Silver Carbene Complexes

Overview
Journal Mol Pharm
Specialty Pharmacology
Date 2012 Oct 3
PMID 23025592
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Degradable acetalated dextran (Ac-DEX) nanoparticles were prepared and loaded with a hydrophobic silver carbene complex (SCC) by a single-emulsion process. The resulting particles were characterized for morphology and size distribution using scanning electron microscopy (SEM), transmission electron microscopy (TEM), and dynamic light scattering (DLS). The average particle size and particle size distribution were found to be a function of the ratio of the organic phase to the surfactant containing aqueous phase with a 1:5 volume ratio of Ac-DEX CH(2)Cl(2) (organic):PBS (aqueous) being optimal for the formulation of nanoparticles with an average size of 100 ± 40 nm and a low polydispersity. The SCC loading was found to increase with an increase in the SCC quantity in the initial feed used during particle formulation up to 30% (w/w); however, the encapsulation efficiency was observed to be the best at a feed ratio of 20% (w/w). In vitro efficacy testing of the SCC loaded Ac-DEX nanoparticles demonstrated their activity against both Gram-negative and Gram-positive bacteria; the nanoparticles inhibited the growth of every bacterial species tested. As expected, a higher concentration of drug was required to inhibit bacterial growth when the drug was encapsulated within the nanoparticle formulations compared with the free drug illustrating the desired depot release. Compared with free drug, the Ac-DEX nanoparticles were much more readily suspended in an aqueous phase and subsequently aerosolized, thus providing an effective method of pulmonary drug delivery.

Citing Articles

Metal complexes of backbone-halogenated imidazol-2-ylidenes.

Bugarin A, Patil S, Tran R, Marichev K Inorganica Chim Acta. 2024; 572.

PMID: 39156221 PMC: 11326507. DOI: 10.1016/j.ica.2024.122263.


Structure-Activity Relationships in NHC-Silver Complexes as Antimicrobial Agents.

Ronga L, Varcamonti M, Tesauro D Molecules. 2023; 28(11).

PMID: 37298911 PMC: 10254942. DOI: 10.3390/molecules28114435.


Tumor Microenvironment-Based Stimuli-Responsive Nanoparticles for Controlled Release of Drugs in Cancer Therapy.

Zhou W, Jia Y, Liu Y, Chen Y, Zhao P Pharmaceutics. 2022; 14(11).

PMID: 36365164 PMC: 9694300. DOI: 10.3390/pharmaceutics14112346.


Pegylated-polycaprolactone nano-sized drug delivery platforms loaded with biocompatible silver(i) complexes for anticancer therapeutics.

Varna D, Christodoulou E, Gounari E, Apostolidou C, Landrou G, Papi R RSC Med Chem. 2022; 13(7):857-872.

PMID: 35923721 PMC: 9298185. DOI: 10.1039/d2md00046f.


Piperine-Loaded Glycyrrhizic Acid- and PLGA-Based Nanoparticles Modified with Transferrin for Antitumor : Piperine-Loaded Glycyrrhizic Acid- and PLGA-Based Nanoparticles.

Li S, Guo J, Tian Z, Chen J, Gou G, Niu Y AAPS PharmSciTech. 2021; 22(7):239.

PMID: 34590204 DOI: 10.1208/s12249-021-02123-6.


References
1.
Russell A, HUGO W . Antimicrobial activity and action of silver. Prog Med Chem. 1994; 31:351-70. DOI: 10.1016/s0079-6468(08)70024-9. View

2.
FOX Jr C . Silver sulfadiazine--a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns. Arch Surg. 1968; 96(2):184-8. DOI: 10.1001/archsurg.1968.01330200022004. View

3.
Ulery B, Nair L, Laurencin C . Biomedical Applications of Biodegradable Polymers. J Polym Sci B Polym Phys. 2011; 49(12):832-864. PMC: 3136871. DOI: 10.1002/polb.22259. View

4.
Simoes M . Antimicrobial strategies effective against infectious bacterial biofilms. Curr Med Chem. 2011; 18(14):2129-45. DOI: 10.2174/092986711795656216. View

5.
Hindi K, Ditto A, Panzner M, Medvetz D, Han D, Hovis C . The antimicrobial efficacy of sustained release silver-carbene complex-loaded L-tyrosine polyphosphate nanoparticles: characterization, in vitro and in vivo studies. Biomaterials. 2009; 30(22):3771-9. PMC: 2801440. DOI: 10.1016/j.biomaterials.2009.03.044. View